CoC honors 90 cancer care facilities with Outstanding Achievement Award

NewsGuard 100/100 Score

The Commission on Cancer (CoC) of the American College of Surgeons has granted its Outstanding Achievement Award to a select group of 90 currently accredited and newly accredited cancer programs across the United States as a result of surveys performed during 2010. The list of cancer facilities that received the award can be found online at this location: http://www.facs.org/cancer/coc/outstandingachievement2010list.html.

Established in 2004, the CoC Outstanding Achievement Award (OAA) is designed to recognize cancer programs that strive for excellence in providing quality care to cancer patients. The award is granted to facilities that demonstrate a Commendation level of compliance with seven standards that represent six areas of cancer program activity: cancer committee leadership, cancer data management, clinical management, research, community outreach, and quality improvement. The level of compliance with the seven standards is determined during an on-site evaluation by a physician surveyor. In addition, facilities must receive a compliance rating for the remaining 29 cancer program standards. The 90 programs that received the OAA following surveyor visits in 2010 represent approximately 17 percent of programs surveyed during this period. A majority of recipients are community-based facilities; however, teaching hospitals, NCI-designated Comprehensive Cancer Centers, Pediatric, and Network Cancer Programs also received the award.

Established in 1922 by the American College of Surgeons, the Commission on Cancer is a consortium of professional organizations dedicated to improving survival and quality of life for cancer patients through standard-setting, prevention, research, education, and the monitoring of comprehensive quality care. Its membership includes Fellows of the American College of Surgeons and representatives of 47 national organizations that reflect the full spectrum of cancer care.

The CoC's core functions include setting standards for quality, multidisciplinary cancer patient care; surveying facilities to evaluate compliance with the 36 CoC standards; collecting standardized, high-quality data from accredited facilities; and using the data to develop effective educational interventions to improve cancer care outcomes at the national, state, and local levels. There are currently more than 1,500 CoC-accredited cancer programs representing 25 percent of all hospitals in the U.S. and Puerto Rico. These CoC-accredited facilities diagnose and/or treat 71 percent of all newly diagnosed cancer patients each year. Receiving care at a CoC-accredited cancer program ensures that a patient will have access to the full quality spectrum of comprehensive cancer care close to home.

In addition, cancer patients' data are reported by each CoC-accredited cancer program to the CoC's National Cancer Data Base (NCDB), a joint program with the American Cancer Society (ACS). These data account for approximately two-thirds of all newly diagnosed cancer cases in the U.S. each year, and are used regularly to monitor the quality of patient care delivered in CoC-accredited cancer programs and to improve cancer care outcomes at both the national and local level.

Source: Commission on Cancer

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Triple-negative breast cancer patients with high immune cell levels have lower relapse risk after surgery